Neuroinflammation and depressive disorder: The role of the hypothalamus

J Clin Neurosci. 2020 May:75:5-10. doi: 10.1016/j.jocn.2020.03.005. Epub 2020 Mar 23.

Abstract

Data accumulated over the last two decades has demonstrated that hypothalamic inflammation plays an important role in the etiopathogenesis of the most prevalent diseases, such as cardiovascular diseases, metabolic syndrome, and even cancer. Recent findings indicate that hypothalamic inflammation is also associated with stress exposure and certain psychiatric diseases, such as depressive disorder. Mechanistic studies have shown that intense and/or chronic stress exposure is accompanied by the synthesis of inflammatory molecules in the hypothalamus, altered hypothalamic-pituitary-adrenal axis activity, and development of glucocorticoid resistance. Consequently, these factors might play a role in the etiopathogenesis of psychiatric disorders. We propose that hypothalamic inflammation represents an interconnection between somatic diseases and depressive disorder. These assumptions are discussed in this mini-review in the light of available data from studies focusing on hypothalamic inflammation.

Keywords: Depressive disorder; HPA axis; Hypothalamus; Inflammation; Stress.

Publication types

  • Review

MeSH terms

  • Animals
  • Depressive Disorder / immunology*
  • Humans
  • Hypothalamo-Hypophyseal System / immunology
  • Hypothalamo-Hypophyseal System / pathology*
  • Neuroimmunomodulation / physiology*
  • Pituitary-Adrenal System / immunology
  • Pituitary-Adrenal System / pathology*
  • Stress, Psychological / immunology
  • Stress, Psychological / pathology